Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Nuffield Health & Icon Group Form Strategic Partnership for UK Oncology Services

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Haemonetics Wins FDA Approval for Vascade...

Haemonetics has secured an expanded regulatory milestone in the...

FDA Clears Medtronic Stealth Axis for...

Medtronic’s Stealth Axis FDA clearance marks an expansion of...

Philips AI DeviceGuide Gets FDA Approval...

Regulatory clearance has been secured by Philips from the...

Nuffield Health and Icon Group have agreed to form a strategic partnership to provide advanced cancer care services in the UK.

This partnership is driven by the shared dedication to offering the best possible care and a seamless experience for UK patients dealing with cancer. The initial phase of their collaboration appears to centre around enhancing radiotherapy treatment. This partnership puts patients first and is led by medical experts. It aims to offer individualised treatment plans and advanced treatments for the best possible care and better results for patients.

Together this partnership with Icon Group, aims to address the growing need for cancer care in the UK. Initially, the main focus will be on utilising world-renowned expertise in radiotherapy to benefit patients.

This partnership between Nuffield Health and Icon Group allows to combine their efforts in tackling the challenges posed by cancer in the UK. Further, this partnership works together to make radiotherapy more accessible across the region, thus improving the options available for cancer patients.

 

MEDICAL FAIR ASIA 2026

Latest stories

Related stories

Haemonetics Wins FDA Approval for Vascade MVP XL System

Haemonetics has secured an expanded regulatory milestone in the...

FDA Clears Medtronic Stealth Axis for Cranial, ENT Uses

Medtronic’s Stealth Axis FDA clearance marks an expansion of...

Philips AI DeviceGuide Gets FDA Approval for Cardiac Use

Regulatory clearance has been secured by Philips from the...

GE HealthCare Drives Cardio-Oncology Care in EU COMPASS

GE HealthCare has taken on the role of lead...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »